Results 171 to 180 of about 3,797,017 (297)

Caddoan Texts

open access: yes
Intro -- Contents -- Preface -- Arikara Texts / Douglas R. Parks -- Arikara Texts / Allan R. Taylor -- Caddo Texts / Wallace L. Chafe -- Kitsai Texts / Alexander Lesser -- Pawnee Texts: Skiri and South Band / Douglas R.
Parks, Douglas R.
core  

Characterization of Anticholinergic Medication Use and Its Associations With Everyday Memory Problems and Cognitive Decline in Autistic Adults With Higher Support Needs

open access: yesAutism Research, EarlyView.
ABSTRACT Among older adults in the general population, medications with anticholinergic (AC) effects are associated with declines in cognitive functioning and with dementia and Alzheimer's disease. Autistic people have high rates of co‐occurring medical conditions and polypharmacy across the lifespan; thus, they may be at particularly high risk of ...
Goldie A. McQuaid   +2 more
wiley   +1 more source

LEGAL TEXTS AND THEIR CHARACTERISTICS

open access: yes
Legal texts play a crucial role in regulating social relations and ensuring justice in society. These texts are characterized by precision, formality, and a specialized vocabulary, distinguishing them from other types of discourse. Their rigid structure and complex syntax ensure that legal provisions are applied consistently and interpreted ...
openaire   +1 more source

Caring for Chosen Family: A Scoping Review of Clinical Work With Chosen Family. [PDF]

open access: yesFam Process
Jenicek A   +4 more
europepmc   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola   +5 more
wiley   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy